Lo Re, G., Santeufemia, D. A., Foltran, L., Bidoli, E., Basso, S. M., & Lumachi, F. (2015). Prognostic factors of survival in patients treated with nab-paclitaxel plus gemcitabine regimen for advanced or metastatic pancreatic cancer: A single institutional experience. Oncotarget.
Citação norma ChicagoLo Re, Giovanni, Davide A. Santeufemia, Luisa Foltran, Ettore Bidoli, Stefano M.M Basso, and Franco Lumachi. "Prognostic Factors of Survival in Patients Treated With Nab-paclitaxel Plus Gemcitabine Regimen for Advanced or Metastatic Pancreatic Cancer: A Single Institutional Experience." Oncotarget 2015.
Citação norma MLALo Re, Giovanni, et al. "Prognostic Factors of Survival in Patients Treated With Nab-paclitaxel Plus Gemcitabine Regimen for Advanced or Metastatic Pancreatic Cancer: A Single Institutional Experience." Oncotarget 2015.